Arteris, INC Form 4 insider transactions

Arteris director Antonio J. Viana transferred 5,071 common shares to the Viana Family Trust, while also receiving 5,071 shares from the trust.

Nicholas Hawkins, CFO of Arteris, Inc., sold 19,299 shares of common stock at an average price of $8.1377 on November 6, 2024, under a pre-arranged 10b5-1 trading plan.

Director Antonio J. Viana of Arteris, Inc. sold 2,781 shares of common stock at an average price of $6.8377 on November 1, 2024, under a pre-arranged 10b5-1 trading plan.

Director Joachim Kunkel acquired 312 shares of Arteris, Inc. common stock as retainer fees in lieu of cash on October 5, 2024.

Director Antonio J. Viana acquired 2,580 shares of Arteris, Inc. common stock as fully vested restricted stock in lieu of cash retainer fees.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold 3,615 shares of common stock at an average price of $7.1302 per share under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold 4,958 shares of common stock at an average price of $7.1301 on October 4, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock to cover tax liabilities arising from the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of company stock on October 2nd and 3rd, 2024, to cover tax liabilities and as part of a pre-arranged trading plan.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on October 2, 2024, to cover tax liabilities arising from the release of restricted stock units.

Nicholas Hawkins, CFO of Arteris Inc., sold shares of common stock on October 1st and 2nd, 2024, under a pre-arranged 10b5-1 trading plan.

Director Joachim Kunkel reports acquiring 40,096 shares of Arteris, Inc. common stock through restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock to cover tax liabilities arising from the release of restricted stock units.

Director Wayne C. Cantwell sold 15,000 shares of Arteris, Inc. common stock on September 6, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,955 shares of common stock at an average price of $7.2587 on September 5, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on September 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on September 3, 2024, to cover tax liabilities related to the release of restricted stock units.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on September 3, 2024, to cover tax liabilities related to the release of restricted stock units and under a pre-arranged 10b5-1 trading plan.

Charles Janac, CEO of Arteris Inc., sold 1,348 shares of common stock on September 3, 2024, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan on August 1, 2024.

Antonio J. Viana, a director at Arteris, Inc., filed an amended Form 4 to correct the number of shares sold on June 7, 2024, and the total shares beneficially owned following the transaction.

Director Antonio J. Viana acquired 2,491 shares of Arteris, Inc. common stock on July 5, 2024, in lieu of cash retainer fees.

Paul Alpern, VP and General Counsel of Arteris, Inc., reported selling 3,615 shares of common stock at an average price of $7.1759 on July 5, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold 1,262 shares of common stock at an average price of $7.175 per share on July 5, 2024, under a pre-arranged 10b5-1 trading plan.

Nicholas B. Hawkins, VP and CFO of Arteris, Inc., sold shares of common stock on July 2nd and 3rd, 2024, to cover tax liabilities related to the release of restricted stock units.

Charles Janac, President and CEO of Arteris, Inc., executed multiple sales of common stock between July 1st and July 3rd, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on July 1st and 2nd, 2024, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports exercising stock options and selling shares to cover tax obligations, according to a Form 4 filing.

Director Antonio J. Viana of Arteris, Inc. sold 2,836 shares of common stock at an average price of $8.1026 on June 10, 2024, under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza transfers shares to a revocable trust, affecting both direct and indirect ownership of Arteris, Inc. stock.